关于暴露前预防作为中东地区降低艾滋病毒风险策略的系统文献综述
A Systematic Literature Review on Pre-exposure Prophylaxis as a Strategy for HIV Risk Reduction in the Middle East.
作者信息
Chaponda Mas, AlHammadi Ahmed A, Alsaeed Ali, Ali Batool, Al Salman Jameela, Alosaimi Roaa S
机构信息
Infectious Department, Communicable Diseases Center, Qatar University, Doha, QAT.
Department of Internal Medicine, AlRahba Hospital, Abu Dhabi Health Services, Abu Dhabi, ARE.
出版信息
Cureus. 2025 Mar 19;17(3):e80842. doi: 10.7759/cureus.80842. eCollection 2025 Mar.
Pre-exposure prophylaxis (PrEP) has emerged as a crucial tool in HIV prevention globally, yet its implementation in the Middle East and North Africa (MENA) region faces unique challenges. PrEP is expected to be effective in reducing HIV transmission. However, there is limited comprehensive data about its awareness, utilization, and effectiveness within MENA countries. The region's distinct cultural, social, and healthcare system characteristics create specific barriers that must be addressed. This study aims to evaluate PrEP's value and effectiveness and to develop targeted recommendations for overcoming barriers and expanding PrEP programs to better serve the region's specific needs and populations at risk. We searched PubMed, Scopus, and Web of Science databases through October 2024, using keywords related to HIV, PrEP, and the MENA region. Eligible studies included peer-reviewed clinical research on PrEP use in MENA countries, focusing on high-risk populations. Two independent reviewers screened titles, abstracts, and full texts using the Rayyan software, with disagreements resolved by a senior reviewer. Studies across the MENA region showed varying levels of PrEP awareness and willingness to use, with MSM communities showing higher interest. While PrEP proved effective for HIV prevention when properly used, implementation faced barriers, including costs, stigma, and accessibility. Despite the potential of PrEP implementation in HIV prevention, its efficacy in the MENA region remains unproven due to a lack of clinical studies. Successful implementation of PrEP in this region requires addressing key challenges, including financial accessibility, awareness, stigma, and healthcare integration. Morocco's pilot program serves as a promising example, but broader adoption must focus on improving accessibility and affordability. Future efforts should tailor interventions to meet the needs of at-risk populations, with an emphasis on enhancing adherence and retention rates to ensure effectiveness in diverse MENA settings.
暴露前预防(PrEP)已成为全球预防艾滋病毒的关键工具,但其在中东和北非(MENA)地区的实施面临独特挑战。PrEP有望有效减少艾滋病毒传播。然而,关于其在中东和北非国家的知晓度、利用率和有效性的综合数据有限。该地区独特的文化、社会和医疗体系特征造成了必须加以解决的特定障碍。本研究旨在评估PrEP的价值和有效性,并制定有针对性的建议,以克服障碍并扩大PrEP项目,从而更好地满足该地区的特定需求和高危人群的需求。我们检索了截至2024年10月的PubMed、Scopus和科学网数据库,使用了与艾滋病毒、PrEP和中东和北非地区相关的关键词。符合条件的研究包括关于中东和北非国家PrEP使用情况的同行评审临床研究,重点关注高危人群。两名独立评审员使用Rayyan软件筛选标题、摘要和全文,如有分歧由一名资深评审员解决。中东和北非地区的研究表明,PrEP的知晓度和使用意愿各不相同,男男性行为者群体表现出更高的兴趣。虽然PrEP在正确使用时被证明对预防艾滋病毒有效,但其实施面临障碍,包括成本、耻辱感和可及性。尽管PrEP在预防艾滋病毒方面有实施潜力,但由于缺乏临床研究,其在中东和北非地区的疗效仍未得到证实。在该地区成功实施PrEP需要应对关键挑战,包括经济可及性、知晓度、耻辱感和医疗整合。摩洛哥的试点项目是一个很有前景的例子,但更广泛的采用必须侧重于提高可及性和可承受性。未来的努力应根据高危人群的需求调整干预措施,重点是提高依从性和留存率,以确保在中东和北非地区的不同环境中取得成效。
相似文献
Cochrane Database Syst Rev. 2022-2-1
本文引用的文献
J Int Assoc Provid AIDS Care. 2024
Int J Environ Res Public Health. 2022-7-20